ProfileGDS4718 / 233929_x_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 90% 88% 83% 87% 85% 83% 80% 83% 88% 85% 86% 88% 79% 86% 82% 83% 82% 82% 80% 97% 82% 84% 83% 84% 85% 84% 87% 92% 89% 84% 76% 84% 87% 85% 84% 78% 83% 86% 84% 81% 84% 85% 85% 81% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.315690
GSM549102patient 115, normal, homogenized [OPG study]8.8013588
GSM549104patient 119, normal, homogenized [OPG study]8.3002983
GSM549108patient 138, normal, homogenized [OPG study]8.5908887
GSM549119patient 077, normal, homogenized [OPG study]8.3979685
GSM549133patient 032, cancer, homogenized [OPG study]8.4094483
GSM549139patient 042, cancer, homogenized [OPG study]7.9111780
GSM549099patient 107, normal, homogenized [OPG study]8.1013983
GSM549109patient 139, normal, homogenized [OPG study]8.8078388
GSM549110patient 046, normal, homogenized [OPG study]8.4043385
GSM549114patient 063, normal, homogenized [OPG study]8.7151186
GSM549122patient 082, normal, homogenized [OPG study]8.8765688
GSM549134patient 033, cancer, homogenized [OPG study]7.7922479
GSM549136patient 036, cancer, homogenized [OPG study]8.687486
GSM549140patient 044, cancer, homogenized [OPG study]8.2260382
GSM549111patient 047, normal, homogenized [OPG study]8.2225283
GSM549113patient 057, normal, homogenized [OPG study]8.1934282
GSM549132patient 031, cancer, homogenized [OPG study]8.1156482
GSM549137patient 038, cancer, homogenized [OPG study]7.9068180
GSM549142patient 047, cancer, homogenized [OPG study]10.239397
GSM549100patient 110, normal, homogenized [OPG study]7.9895882
GSM549107patient 135, normal, homogenized [OPG study]8.3164984
GSM549115patient 068, normal, homogenized [OPG study]8.3685383
GSM549116patient 072, normal, homogenized [OPG study]8.4587984
GSM549120patient 078, normal, homogenized [OPG study]8.5120185
GSM549131patient 030, cancer, homogenized [OPG study]8.386284
GSM549118patient 074, normal, homogenized [OPG study]8.776287
GSM549129patient 027, cancer, homogenized [OPG study]9.3624492
GSM549123patient 088, normal, homogenized [OPG study]9.0127989
GSM549124patient 006, cancer, homogenized [OPG study]8.2157384
GSM549126patient 015, cancer, homogenized [OPG study]7.4032176
GSM549128patient 025, cancer, homogenized [OPG study]8.3922284
GSM549103patient 117, normal, homogenized [OPG study]8.6795587
GSM549117patient 073, normal, homogenized [OPG study]8.511685
GSM549138patient 041, cancer, homogenized [OPG study]8.3262684
GSM549141patient 045, cancer, homogenized [OPG study]7.795878
GSM549130patient 028, cancer, homogenized [OPG study]8.1183283
GSM549101patient 111, normal, homogenized [OPG study]8.5514486
GSM549105patient 128, normal, homogenized [OPG study]8.3264684
GSM549106patient 134, normal, homogenized [OPG study]8.121181
GSM549112patient 048, normal, homogenized [OPG study]8.3942884
GSM549125patient 011, cancer, homogenized [OPG study]8.4729185
GSM549127patient 024, cancer, homogenized [OPG study]8.4865285
GSM549135patient 035, cancer, homogenized [OPG study]8.064581